Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026)
Sintx Technologies' (SINT) quarterly Change in Accured Expenses came in at $659000.0 in Q1 2026, up 1838.24% year-on-year from $34000.0 in Q1 2025, and up 381.62% quarter-over-quarter from -$234000.0 in Q4 2025.
Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Sintx Technologies' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $659000.0 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 1838.24% year-over-year to $659000.0 in Q1 2026; TTM through Mar 2026 was $425000.0, a 542.71% increase from a year earlier, with the FY2025 full-year figure at -$200000.0, down 9900.0% from the prior year.
- Change in Accured Expenses climbed to $659000.0 in Q1 2026 per SINT's latest filing, from -$234000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $786000.0 in Q4 2024 and bottomed at -$636000.0 in Q3 2024.
- The 5-year median for Change in Accured Expenses is $34000.0 (2025), against an average of $39470.6.
- Across the five-year window, Change in Accured Expenses plunged 11333.33% in 2023 and soared 1838.24% in 2026, its largest moves.
- Year by year, Change in Accured Expenses stood at $258000.0 in 2022, then surged by 38.76% to $358000.0 in 2023, then surged by 119.55% to $786000.0 in 2024, then plunged by 129.77% to -$234000.0 in 2025, then jumped by 381.62% to $659000.0 in 2026.
- Per Business Quant, the three latest SINT Change in Accured Expenses figures stand at $659000.0 (Q1 2026), -$234000.0 (Q4 2025), and $251000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 659,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | -234,000.00 |
| Dec 31, 2025 | -234,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | -251,000.00 |
| Jun 30, 2025 | -251,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 786,000.00 |
| Dec 31, 2024 | 786,000.00 |
| Sep 30, 2024 | -636,000.00 |
| Sep 30, 2024 | -636,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 358,000.00 |
| Dec 31, 2023 | 358,000.00 |